Page last updated: 2024-08-21

2'-deoxyadenosine triphosphate and Granulocytic Leukemia, Chronic

2'-deoxyadenosine triphosphate has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarado, Y; Brown, RA; Cahill, A; Cortes, JE; DiPersio, JF; Faderl, S; Fracasso, PM; Gandhi, V; Garcia-Manero, G; Giles, FJ; Kantarjian, HM; Lambert, P; Plunkett, W; Samson, T; Sznol, M; Thomas, DA; Verstovsek, S; Wright, LP1

Trials

1 trial(s) available for 2'-deoxyadenosine triphosphate and Granulocytic Leukemia, Chronic

ArticleYear
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia.
    Leukemia research, 2003, Volume: 27, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Deoxyadenine Nucleotides; Deoxyguanine Nucleotides; DNA; DNA, Neoplasm; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Middle Aged; Pyridines; Ribonucleotide Reductases; Safety; Thiosemicarbazones

2003
chemdatabank.com